• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Imaging and Intervention

Diffusion tensor imaging may aid in Parkinson’s diagnosis

byDylan WolmanandAaron Maxwell, MD
January 23, 2015
in Imaging and Intervention, Neurology
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. Diffusion tensor imaging (DTI) of marmoset brains following chemically-induced Parkinsonism showed an increase in nigrostriatial diffusivity with a loss of corresponding fiber tracts as compared to controls, indicating a potential future role for imaging in the diagnosis of Parkinson’s disease.

Evidence Rating Level: 3 (Average)

Study Rundown: In Parkinson’s disease (PD), degeneration of the nigrostriatal fibers projecting from the substantia nigra to the striatum are progressively lost, leading to the disease’s hallmark tremor and rigidity. This finding has been well defined histologically but is currently of limited use in the diagnosis and assessment of disease progression in a living patient. Diffusion tensor imaging (DTI) is a magnetic resonance-based imaging modality that allows for non-invasive visualization of fiber tracts in tissue based on the direction-dependent—or anisotropic—nature of water diffusion along such tracts. In the current study, a DTI-based tractographic examination of the difference in diffusivity and subsequent loss of fiber tracts along the nigrostriatal pathway was undertaken between normal marmosets and those treated with MPTP, a toxin specific to the dopaminergic neurons of the substantia nigra. In this chemically-induced primate model of Parkinsonism, the study authors found that DTI could be successfully used in detecting the nigrostriatal degeneration characteristic of PD, as represented by increase in localized axial diffusivity with a relative loss of fiber tracts. These findings were confirmed by subsequent histologic examination. The study was technologically limited by necessity for higher resolution imaging; particularly, it utilized long scan times and high field strengths, the use of which are currently limited to research use only. Future studies utilizing practical tractographic imaging parameters in humans with and without PD are warranted, as are additional primate studies examining a genetic, rather than chemically-induced, PD model.

Click to read the study in Radiology

Relevant Reading: Mapping track density changes in nigrostriatal and extranigal pathways in Parkinson’s disease

In-Depth [animal study]: Nine male marmosets underwent longitudinal, region-of-interest (ROI)-based DTI evaluation of the nigrostriatal pathway before and 10 weeks after MPTP administration using a 7T MR imaging system. Echo-planar DTI images were acquired continuously over the course of one week while animals were anesthetized and immobilized to reduce artifact degradation. The animals were subsequently euthanized for histologic and microscopic tractographic examination of the nigrostriatal pathway to confirm differences seen on longitudinal DTI. After MPTP administration, all animals displayed the characteristic symptoms of Parkinson disease, and a significant increase in the mean axial and radial diffusivity was seen bilaterally in the basal ganglia, extending up from the substantia nigra to the cerebral peduncles (P = 0.033). Specific ROI analysis of the nigrostriatal pathway revealed a 27% increase in diffusivity between the control and MPTP-treated states (P = 0.005 and P = 0.004 in the right and left cortices, respectively.) These findings were confirmed on histologic and microscopic tractographic examination, showing specific denervation of the nigrostriatal pathway and a significant reduction in fiber bundles in the MPTP-treated state.

RELATED REPORTS

Exenatide does not slow Parkinson’s disease progression compared to placebo

The Scan by 2 Minute Medicine®: Florida Trans Youth Care Ban Halted, Tendon Injuries in Basketball, A Blood Test for Parkinson’s Disease, Screen Time and Language Development

Lixisenatide as a treatment for early Parkinson’s disease progression

More from this author: Perfusion imaging may predict successful thrombolysis in acute stroke, Stroke expansion following intra-arterial therapy may explain worse outcomes, Imaging of atherosclerotic inflammation possible with fluorine MRI

Image: CC/Jensflorian/Wikimedia Commons

©2014 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. No article should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2 Minute Medicine, Inc.

Tags: diffusion tensor imagingParkinson’s Disease
Previous Post

Preoperative coagulation status may predict liver transplant complications

Next Post

Adjuvant radiation decreases local recurrence in low-risk breast cancer

RelatedReports

Levodopa for Parkinson’s disease more effective than newer generation therapies
Chronic Disease

Exenatide does not slow Parkinson’s disease progression compared to placebo

April 25, 2025
The Scan by 2 Minute Medicine®:  Ultra-Trail du Mont-Blanc, Taylor Swift, NBA rookie Chet Holmgren and Magic Mushrooms!
The Scan by 2 Minute Medicine®

The Scan by 2 Minute Medicine®: Florida Trans Youth Care Ban Halted, Tendon Injuries in Basketball, A Blood Test for Parkinson’s Disease, Screen Time and Language Development

June 25, 2024
Brain lesions on MRI linked with subsequent increased stroke risk
Chronic Disease

Lixisenatide as a treatment for early Parkinson’s disease progression

May 23, 2024
The LEAP trial: levodopa not associated with a disease-modifying effect in Parkinson’s disease
Chronic Disease

Freezing of gait is associated with sleep disorders in patients with Parkinson’s disease

January 9, 2024
Next Post
Adjuvant radiation decreases local recurrence in low-risk breast cancer

Adjuvant radiation decreases local recurrence in low-risk breast cancer

Severe maternal childhood abuse associated with autism in offspring

Video therapy may improve behavioral outcomes in infants at risk for autism

MRI screening may improve osteonecrosis outcomes in children with leukemia

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • SGLT2 inhibitors may delay cognitive impairment in elderly patients with heart failure
  • Nerandomilast slows decline in FVC in idiopathic pulmonary fibrosis
  • Mazdutide significantly reduces weight in adults with overweight or obesity
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.